6-Phenylpurines were identified as novel, ATP-competitiveinhibitors of protein kinase B (PKB/Akt) from a fragment-based screenand were rapidly progressed to potent compounds using iterativeprotein-ligand crystallography with a PKA-PKB chimeric protein.An elaborated lead compound showed cell growth inhibition and effectson cellular signaling pathways characteristic of PKB inhibition.